Bayer AG - SWOT, Strategy and Corporate Finance Report
Published: June 2013 · Publisher: MarketLine
Bayer AG - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
- Description
- Table of Contents
- Ask a Question
Bayer AG - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.
Features:
- Detailed information on Bayer AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bayer AG in the form of a SWOT analysis
- An in-depth view of the business model of Bayer AG including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Bayer AG
- Intelligence on Bayer AGnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bayer AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Bayer (or ‘the group’) is a Germany-based global chemical and pharmaceutical business group. It operates in Asia Pacific, Europe, North America, Latin America, Africa, and the Middle East. It is headquartered in Leverkusen, Germany, and employed about 110,500 people as on December 31, 2012. The group recorded revenues of E39,760 million ($51,123.4 million*) during the financial year ended December 2012 (FY2012), an increase of 8.8% over FY2011. The operating profit of the group was E3,960 million ($5,091.8 million*) during FY2012, a decrease of 4.6% compared with FY2011. The net profit was E2,446 million ($3,145.1 million*) in FY2012, a decrease of 1% compared with FY2011. *Calculated using a constant conversion rate of E1 = $1.2858 for the financial year ended December 31, 2012.
Reasons to Purchase:
- Gain understanding of Bayer AG and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Bayer AG as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Bayer AG’s business structure, strategy and prospects
Features:
- Detailed information on Bayer AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bayer AG in the form of a SWOT analysis
- An in-depth view of the business model of Bayer AG including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Bayer AG
- Intelligence on Bayer AGnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bayer AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Bayer (or ‘the group’) is a Germany-based global chemical and pharmaceutical business group. It operates in Asia Pacific, Europe, North America, Latin America, Africa, and the Middle East. It is headquartered in Leverkusen, Germany, and employed about 110,500 people as on December 31, 2012. The group recorded revenues of E39,760 million ($51,123.4 million*) during the financial year ended December 2012 (FY2012), an increase of 8.8% over FY2011. The operating profit of the group was E3,960 million ($5,091.8 million*) during FY2012, a decrease of 4.6% compared with FY2011. The net profit was E2,446 million ($3,145.1 million*) in FY2012, a decrease of 1% compared with FY2011. *Calculated using a constant conversion rate of E1 = $1.2858 for the financial year ended December 31, 2012.
Reasons to Purchase:
- Gain understanding of Bayer AG and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Bayer AG as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Bayer AG’s business structure, strategy and prospects
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
Bayer AG: Company Overview
Bayer AG: Overview and Key Facts
Bayer AG: Overview
Bayer AG: Key Facts
Bayer AG: Key Employees
Bayer AG: Key Employee Biographies
Bayer AG: Major Products and Services
Bayer AG: Company History
Bayer AG: Management Statement
Bayer AG: Locations and Subsidiaries
Bayer AG: Key Competitors
Bayer AG: Company Analysis
Bayer AG: Business Description
Bayer AG: SWOT Analysis
Bayer AG: SWOT Overview
Bayer AG: Strengths
Bayer AG: Weaknesses
Bayer AG: Opportunities
Bayer AG: Threats
Bayer AG: Financial Analysis
Bayer AG: Financial Overview
Bayer AG: Five Year Company Financials
Bayer AG: Key Income Statement Data
Bayer AG: Key Balance Sheet Data
Bayer AG: Key Cash Flow Data
Bayer AG: Key Market Data
Bayer AG: Valuation Ratios
Bayer AG: Profitability Ratios
Bayer AG: Management Efficiency Ratios
Bayer AG: Financial Strength Ratios
Bayer AG: Operational Efficiency Ratios
Bayer AG: Others
Bayer AG: Corporate Financial Deals Activity
Bayer AG: Financial Deals Overview
Bayer AG: Targets and Partners
Bayer AG: Top Deals 2009 - 2013YTD*
Bayer AG: Advisors
Bayer AG: Top Legal Advisors
Bayer AG: Top Financial Advisors
Bayer AG: Mergers and Acquisitions
Bayer AG: Corporate Venturing
Bayer AG: Partnership
Bayer AG: Divestments
Bayer AG: Recent Developments
Bayer AG: News and Events Summary
Bayer AG: Business Expansion
Bayer AG: Contracts
Bayer AG: Financial Performance
Bayer AG: Regulatory and Legal Events
Bayer AG: Research & Development
Bayer AG: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Bayer AG: Key Facts
Table 2: Bayer AG: Key Employees
Table 4: Bayer AG: Key Competitors
Table 5: Bayer AG: Key Income Statement Data
Table 6: Bayer AG: Key Balance Sheet Data
Table 7: Bayer AG: Key Cash Flow Data
Table 8: Bayer AG: Key Market Data
Table 9: Bayer AG: Key Growth Ratios
Table 10: Bayer AG: Valuation Ratios
Table 11: Bayer AG: Profitability Ratios
Table 12: Bayer AG: Management Efficiency Ratios
Table 13: Bayer AG: Financial Strength Ratios
Table 14: Bayer AG: Operational Efficiency Ratios
Table 15: Bayer AG: Others
Table 16: Bayer AG: Deal Activity by Deal Type - Volume (TTM*)
Table 17: Bayer AG: M&A Activity by Geography (TTM*)
Table 18: Bayer AG: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 19: Bayer AG: M&A Average Deal Size - Value (US$m)
Table 20: Bayer AG: Targets and Partners
Table 21: Bayer AG: Top Deals 2009 - 2013YTD*
Table 22: Bayer AG: Legal Advisor Ranking by Value (US$m)
Table 23: Bayer AG: Financial Advisor Ranking by Value (US$m)
Table 24: Bayer AG: M&A Volume and Value Trend (2009 - YTD*2013)
Table 25: Bayer AG: M&A Activity by Geography (2009 - YTD*2013)
Table 26: Bayer AG: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Table 27: Bayer AG: Corporate Venturing by Geography (2009 - YTD*2013)
Table 28: Bayer AG: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 29: Bayer AG: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 30: Bayer AG: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 31: Bayer AG: Divestments by Geography (2009 - YTD*2013)
Table 32: Bayer AG: News and Events Summary
Table 33: Bayer AG: Business Expansion
Table 34: Bayer AG: Contracts
Table 35: Bayer AG: Financial Performance
Table 36: Bayer AG: Regulatory and Legal Events
Table 37: Bayer AG: Research & Development
Table 38: Bayer AG: Strategy and Operations
List of Figures
Figure 1: Bayer AG: Revenue to Net Income (2007-2011)
Figure 2: Bayer AG: Revenue/Employee to Net Income/Employee (2007-2011)
Figure 3: Bayer AG: Current Assets to Current Liabilities (2007-2011)
Figure 4: Bayer AG: Assets, Liabilities to Total Equity (2007-2011)
Figure 5: Bayer AG: Free Cash Flow to Cash from Operating Activities (2007-2011)
Figure 6: Bayer AG: Net Change in Cash (2007-2011)
Figure 7: Bayer AG: Market Capitalization to Year-end Share Price (2007-2011)
Figure 8: Bayer AG: Enterprise Value (2007-2011)
Figure 9: Bayer AG: Deal Activity by Deal Type - Volume (TTM*)
Figure 10: Bayer AG: M&A Activity by Geography (TTM*)
Figure 11: Bayer AG: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 12: Bayer AG: M&A Average Deal Size - Value (US$m)
Figure 13: Bayer AG: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 14: Bayer AG: M&A Activity by Geography (2009 - YTD*2013)
Figure 15: Bayer AG: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Figure 16: Bayer AG: Corporate Venturing by Geography (2009 - YTD*2013)
Figure 17: Bayer AG: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 18: Bayer AG: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 19: Bayer AG: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 20: Bayer AG: Divestments by Geography (2009 - YTD*2013)
Bayer AG: Company Overview
Bayer AG: Overview and Key Facts
Bayer AG: Overview
Bayer AG: Key Facts
Bayer AG: Key Employees
Bayer AG: Key Employee Biographies
Bayer AG: Major Products and Services
Bayer AG: Company History
Bayer AG: Management Statement
Bayer AG: Locations and Subsidiaries
Bayer AG: Key Competitors
Bayer AG: Company Analysis
Bayer AG: Business Description
Bayer AG: SWOT Analysis
Bayer AG: SWOT Overview
Bayer AG: Strengths
Bayer AG: Weaknesses
Bayer AG: Opportunities
Bayer AG: Threats
Bayer AG: Financial Analysis
Bayer AG: Financial Overview
Bayer AG: Five Year Company Financials
Bayer AG: Key Income Statement Data
Bayer AG: Key Balance Sheet Data
Bayer AG: Key Cash Flow Data
Bayer AG: Key Market Data
Bayer AG: Valuation Ratios
Bayer AG: Profitability Ratios
Bayer AG: Management Efficiency Ratios
Bayer AG: Financial Strength Ratios
Bayer AG: Operational Efficiency Ratios
Bayer AG: Others
Bayer AG: Corporate Financial Deals Activity
Bayer AG: Financial Deals Overview
Bayer AG: Targets and Partners
Bayer AG: Top Deals 2009 - 2013YTD*
Bayer AG: Advisors
Bayer AG: Top Legal Advisors
Bayer AG: Top Financial Advisors
Bayer AG: Mergers and Acquisitions
Bayer AG: Corporate Venturing
Bayer AG: Partnership
Bayer AG: Divestments
Bayer AG: Recent Developments
Bayer AG: News and Events Summary
Bayer AG: Business Expansion
Bayer AG: Contracts
Bayer AG: Financial Performance
Bayer AG: Regulatory and Legal Events
Bayer AG: Research & Development
Bayer AG: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Bayer AG: Key Facts
Table 2: Bayer AG: Key Employees
Table 4: Bayer AG: Key Competitors
Table 5: Bayer AG: Key Income Statement Data
Table 6: Bayer AG: Key Balance Sheet Data
Table 7: Bayer AG: Key Cash Flow Data
Table 8: Bayer AG: Key Market Data
Table 9: Bayer AG: Key Growth Ratios
Table 10: Bayer AG: Valuation Ratios
Table 11: Bayer AG: Profitability Ratios
Table 12: Bayer AG: Management Efficiency Ratios
Table 13: Bayer AG: Financial Strength Ratios
Table 14: Bayer AG: Operational Efficiency Ratios
Table 15: Bayer AG: Others
Table 16: Bayer AG: Deal Activity by Deal Type - Volume (TTM*)
Table 17: Bayer AG: M&A Activity by Geography (TTM*)
Table 18: Bayer AG: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 19: Bayer AG: M&A Average Deal Size - Value (US$m)
Table 20: Bayer AG: Targets and Partners
Table 21: Bayer AG: Top Deals 2009 - 2013YTD*
Table 22: Bayer AG: Legal Advisor Ranking by Value (US$m)
Table 23: Bayer AG: Financial Advisor Ranking by Value (US$m)
Table 24: Bayer AG: M&A Volume and Value Trend (2009 - YTD*2013)
Table 25: Bayer AG: M&A Activity by Geography (2009 - YTD*2013)
Table 26: Bayer AG: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Table 27: Bayer AG: Corporate Venturing by Geography (2009 - YTD*2013)
Table 28: Bayer AG: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 29: Bayer AG: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 30: Bayer AG: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 31: Bayer AG: Divestments by Geography (2009 - YTD*2013)
Table 32: Bayer AG: News and Events Summary
Table 33: Bayer AG: Business Expansion
Table 34: Bayer AG: Contracts
Table 35: Bayer AG: Financial Performance
Table 36: Bayer AG: Regulatory and Legal Events
Table 37: Bayer AG: Research & Development
Table 38: Bayer AG: Strategy and Operations
List of Figures
Figure 1: Bayer AG: Revenue to Net Income (2007-2011)
Figure 2: Bayer AG: Revenue/Employee to Net Income/Employee (2007-2011)
Figure 3: Bayer AG: Current Assets to Current Liabilities (2007-2011)
Figure 4: Bayer AG: Assets, Liabilities to Total Equity (2007-2011)
Figure 5: Bayer AG: Free Cash Flow to Cash from Operating Activities (2007-2011)
Figure 6: Bayer AG: Net Change in Cash (2007-2011)
Figure 7: Bayer AG: Market Capitalization to Year-end Share Price (2007-2011)
Figure 8: Bayer AG: Enterprise Value (2007-2011)
Figure 9: Bayer AG: Deal Activity by Deal Type - Volume (TTM*)
Figure 10: Bayer AG: M&A Activity by Geography (TTM*)
Figure 11: Bayer AG: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 12: Bayer AG: M&A Average Deal Size - Value (US$m)
Figure 13: Bayer AG: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 14: Bayer AG: M&A Activity by Geography (2009 - YTD*2013)
Figure 15: Bayer AG: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Figure 16: Bayer AG: Corporate Venturing by Geography (2009 - YTD*2013)
Figure 17: Bayer AG: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 18: Bayer AG: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 19: Bayer AG: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 20: Bayer AG: Divestments by Geography (2009 - YTD*2013)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.